192 related articles for article (PubMed ID: 7903289)
1. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression.
Sullivan RP; Mortimer G; Muircheartaigh IO
Ir J Med Sci; 1993 Sep; 162(9):343-7. PubMed ID: 7903289
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
Sarli G; Benazzi C; Preziosi R; Marcato PS
J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.
Betta PG; Bottero G; Pavesi M; Pastormerlo M; Bellinger D; Tallarida F
Surg Oncol; 1993; 2(1):59-63. PubMed ID: 7902763
[TBL] [Abstract][Full Text] [Related]
4. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
5. The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast.
Jeziorski A; Blonski JZ; Niewiadomska H
J Exp Clin Cancer Res; 2000 Mar; 19(1):61-7. PubMed ID: 10840938
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
7. [The relationship of the expression of proliferetron--related antigens Ki67 and PCNA in the cells of ductal breast cancer with the differentiation grade].
Surowiak P; Pudełko M; Maciejczyk A; Dziegiel P; Wojnar A; Zabel M
Ginekol Pol; 2005 Jan; 76(1):9-14. PubMed ID: 15844560
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.
Lörz M; Meyer-Breiting E; Bettinger R
Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683
[TBL] [Abstract][Full Text] [Related]
9. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
Leonardi E; Girlando S; Serio G; Mauri FA; Perrone G; Scampini S; Dalla Palma P; Barbareschi M
J Clin Pathol; 1992 May; 45(5):416-9. PubMed ID: 1350788
[TBL] [Abstract][Full Text] [Related]
10. Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Tsenga A; Thomas-Tsagli E
J Cancer Res Clin Oncol; 1994; 120(7):393-8. PubMed ID: 7910610
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
[TBL] [Abstract][Full Text] [Related]
12. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
13. A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients.
Niewiadomska H; Mirowski M; Stempien M; Olborski B; Blonski JZ; Hanausek M; Wierzbicki R
Neoplasma; 1998; 45(4):216-22. PubMed ID: 9890664
[TBL] [Abstract][Full Text] [Related]
14. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
15. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors].
Wang S; Ma XY; Xia Y; Zhang LH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
20. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
Vartanian RK; Weidner N
Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]